Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Part I. General subjects
-
1. Need for drug delivery systems 1
- Prof. Ana Catarina Silva
-
2. Need for drug delivery systems 2
- Prof. João Nuno Moreira
-
3. Routes of drug delivery
- Prof. Dr. Sven Stegemann
-
4. Transporters in drug delivery
- Dr. Pravin Shende
-
5. The theory and applications of controlled release principles
- Dr. Michael J. Rathbone
- Part II. Routes for drug delivery
-
6. Oral drug delivery
- Dr. Vineet Kumar Rai
-
7. Transdermal drug delivery
- Prof. Sabine Szunerits
-
8. Pulmonary drug delivery
- Prof. Anthony J. Hickey
-
9. Gastrointestinal drug delivery
- Prof. Susan Hua
-
10. Mucoadhesive drug delivery systems
- Dr. Panoraia I. Siafaka
-
11. Ocular drug delivery
- Prof. Emily Dosmar
-
12. Vaginal and uterine drug delivery
- Prof. José Luis Arias Mediano
-
13. Drug-eluting implants
- Dr. Aliasger K. Salem
- Part III. Materials for drug delivery
-
14. Polymers as nanocarriers for controlled drug delivery
- Prof. Dr. Marcelo Calderón
-
15. Polymeric gels for drug delivery
- Dr. G. Roshan Deen
- Ms. Dora Safar
-
16. Liposomes as a drug delivery system
- Dr. G. Roshan Deen
- Ms. Bushra Hasan
- Ms. Renad AlAnsari
-
17. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)
- Prof. Ana Catarina Silva
-
18. Micellar drug delivery
- Prof. Francesco Cellesi
-
19. Nanocrystals in drug delivery
- Prof. Eliana Souto
-
20. Layer-by-layer assemblies for drug delivery
- Prof. Szczepan Zapotoczny
-
21. Inorganic nanostructured interfaces for therapeutic delivery
- Prof. Tejal Desai
-
22. Inorganic porous drug delivery carriers
- Prof. Jessica Rosenholm
- Part IV. Specifics of drug delivery
-
23. Delivery of genes and nucleotides
- Prof. Esam Yahya
-
24. Vaccine delivery
- Prof. Sevda Şenel
- Part V. Drug delivery in various diseases
-
25. Drug delivery for cancer therapeutics
- Prof. Tejraj Aminabhavi
-
26. Nanomedicines for brain diseases
- Prof. Giovanni Tosi
-
27. Drug delivery to the colon
- Prof. Susan Hua
-
28. Role of the lymphatic system in drug absorption
- Dr. Kishor M. Wasan
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Introduction to oral drugs
- Advantages of oral drug delievery
- Disadvantages of oral drug delivery
- Challenges of oral drug delivery
- The gastrointestinal tract
- The GI tract and its functions
- Components of GI tract: mouth
- Components of GI tract: stomach
- Components of GI tract: small intestine (1)
- Components of GI tract: small intestine (2)
- Components of GI tract: large intestine
- Components of GI tract: rectum
- Pre-systemic metabolism/first-pass effect
- The hepatobiliary system
- Enterohepatic circulation
- The intestinal microflora: composition
- The intestinal microflora: functions
- Factors to be considered for oral drug delivery
- Pharmaceutical factors (1)
- Pharmaceutical factors (2)
- Patient-related factors
- Suitable dosage forms
- Course of events that occur in oral drug delivery
- Summary
- Thank you
Topics Covered
- Advantages and disadvantages of oral drug delivery
- Gastrointestinal tract anatomy and function
- GI tract components
- Challenges in oral drug delivery
- Pharmaceutical factors to be considered
- Patient-related factors to be considered
- Suitable dosage forms
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Rai, V.K. (2022, April 28). Oral drug delivery [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/QYTK4042.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Vineet Kumar Rai has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
Hi. My name is Vineet Kumar Rai.
I am an associate professor
in Pharmacy Discipline
and Head of the Department
of Pharmaceutics
at ISF College of
Pharmacy, Moga, Punjab.
The subject of this lecture
is oral drug delivery.
The focus is on the oral route
for both local and systemic uses.
0:20
This slide shows an
outline of the lecture.
After a brief introduction,
the significant advantages,
disadvantages and
challenges associated
with the oral route of
administration will be discussed.
It further includes anatomy of
the gastrointestinal tract,
its components, functions,
different barriers against
oral drug delivery,
factors to be considered
for oral administration
and most suitable dosage forms.
0:48
The introduction slide shows
the paramount importance
of drug delivery.
As far as the
current market share
of the oral drug delivery
system is concerned,
it is about 90%.
At the same time, it
covers nearly 84% of
the best-selling
pharmaceutical products
with a value of 35
billion US dollars.
This market is growing
at a phenomenal rate
that is more than 10% annually.
Hence, these factors prove
the oral route is the
most preferred route
for drug administration.
Why is it so?
1:22
It is because the oral route is
well-known for its
painless administration.
It allows easy administration
by the patient themselves,
since taking anything
orally is convenient.
It offers great
patient compliance.
Furthermore, it is a
cost-effective method
compared with the
other routes and
it doesn't require any
specific or sterile condition
during dosage form development
and administration.
We all practice
self-administration from our mouth
and it doesn't require any
expert for the same purpose.
Additionally, the lumen of
the gastrointestinal tract
offers an enormous
surface area for
drug absorption through
the entire length
of the gastrointestinal tract.
The formulation scientists
always have flexibility
in designing different
dosage forms
for the administration of
the drugs by oral routes.
Therefore, every dosage form
has been developed to date,
ranging from liquid dosage
forms to solid dosage forms.
Moreover, it offers great ease
in scale-up and
large-scale manufacturing.